[CYCC] QoQ Quarter Result on 30-Sep-2009 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
12-Nov-2009
Financial Year
2009
Quarter
30-Sep-2009 [#Q3]
Profit Trend
QoQ- 55.66%
YoY- 82.30%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Revenue 119 271 187 230 266 228 251 -39.28%
PBT -4,163 -5,244 -4,489 -3,329 -7,278 -5,421 -8,181 -36.34%
Tax -230 -133 -152 -205 -233 -358 -238 -2.25%
NP -3,933 -5,111 -4,337 -3,124 -7,045 -5,063 -7,943 -37.49%
Tax Rate - - - - - - - -
Total Cost 4,052 5,382 4,524 3,354 7,311 5,291 8,194 -37.54%
Ratio Analysis
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
NP Margin -3,305.04 -1,885.98 -2,319.25 -1,358.26 -2,648.50 -2,220.61 -3,164.54 2.94%
Per Share
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
EPS -180.70 -270.70 -229.70 -226.51 -579.26 -416.30 -653.10 -57.63%
EPS Diluted -180.70 -270.70 -229.70 -226.51 -579.26 -416.30 -653.10 -57.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.